Anaphylaxis

Anaesthesia Science

Volumn , Issue , 2008, Pages 67-79

  Rose, Michael ^a   Fisher, Malcolm ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Activation; Anaphylaxis; Antibody; Clinical signs; Leukotrienes

Indexed keywords

EID: 68849096868     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470755297.ch5     Document Type: Chapter

References (53)

1. Fisher M, Baldo BA. Anaphylaxis during anaesthesia: current aspects of diagnosis and prevention. Eur J Anaesth 1994; 11: 263-84.
2. Boston Collaborative Drug Surveillance Survey. Druginduced anaphylaxis. JAMA 1973; 224: 613-5.
3. Laxenaire MC, Mertes PM, Groupe d'Etudes des Reactions Anaphylactoides Peranesthesiques. Anaphylaxis during anaesthesia: results of a two-year survey in France. Br J Anaesth 2001; 87: 549-58.
4. Laxenaire MC, Moneret-Vautrin DA, Vervloet D. The French experience of anaphylactoid reactions. Int Anesthesiol Clin 1985; 23: 145-60.
5. Galletly DC, Treuren BC. Anaphylactoid reactions during anaesthesia: seven years' experience of intradermal testing. Anaesthesia 1985; 40: 329-33.
6. Fisher MM, Baldo BA. The incidence and clinical features of anaphylactic reactions during anesthesia in Australia. Ann Fr Anesth Reanim 1993; 12: 97-104.
7. Rose M, Fisher M. Rocuronium: high risk for anaphylaxis? Br J Anaesth 2001; 86: 678-82.
8. Coombs RRA, Gell PGA. Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Gell PGA, Coombs RRA, Lachman PJ, eds. Clinical Aspects of Immunology. Oxford: Blackwell, 1975: 761-81.
9. Bach MK. Mediators of anaphylaxis and inflammation. Annu Rev Microbiol 1982; 36: 371-413.
10. Lorenz W. Histamine release in man. 1975 [classical article]. Agents Actions 1994; 43: 117-31.
11. Tharp MD, Kagey-Sobotka A, Fox CC, et al. Functional heterogeneity of human mast cells from different anatomic sites: in vitro responses to morphine sulfate. J Allergy Clin Immunol 1987; 79: 646-53.
12. Stellato C, de Paulis A, Cirillo R, et al. Heterogeneity of human mast cells and basophils in response to muscle relaxants. Anesthesiol 1991; 74: 1078-86.
13. Lakin J, Blocker T, Strong D, Yocum L. Anaphylaxis to protamine sulphate mediated by a complement dependent IgG antibody. J Allergy Clin Immunol 1978; 61: 102-6.
14. Raper RF, Fisher MM. Profound reversible myocardial depression after anaphylaxis. Lancet 1988; ii: 386-7.
15. Horrow JC. Protamine: a review of its toxicity. Anesth Analg 1985; 64: 348-61.
16. Fisher MM. Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse. Anaesth Intensive Care 1986; 14: 17-21.
17. Clergue F, Auroy Y, Pequignot F, et al. French survey of anesthesia in 1996. Anesthesiol 1999; 91: 1509-20.
18. Fisher MM, Doig GS. Prevention of anaphylactic reactions to anaesthetic drugs. Drug Saf 2004; 27: 393-410.
19. Fisher MM, Outhred A, Bowey CJ. Can clinical anaphylaxis to anaesthetic drugs be predicted from allergic history? Br J Anaesth 1987; 59: 690-2.
20. Fisher MM, More DG. The epidemiology and clinical features of anaphylactic reactions in anaesthesia. Anaesth Intensive Care 1981; 9: 226-34.
21. Ind PW, Causon RC, Brown MJ, Barnes PJ. Circulating catecholamines in acute asthma. Br Med J 1985; 290: 267-9.
22. Kemp SF, Lockey RF. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 2002; 110: 341-8.
23. Ljungstrom KG, Renck H, Strandberg K, et al. Adverse reactions to dextran in Sweden 1970-1979. Acta Chir Scand 1983; 149: 253-62.
24. Garvey LH, Roed-Petersen J, Husum B. Anaphylactic reactions in anaesthetised patients: four cases of chlorhexidine allergy. Acta Anaesthesiol Scand 2001; 45: 1290-4.
25. Garvey LH, Roed-Petersen J, Menne T, Husum B. Danish Anaesthesia Allergy Centre: preliminary results. Acta Anaesthesiol Scand 2001; 45: 1204-9.
26. Baldo BA, Harle DG, Fisher MM. In vitro diagnosis and studies on the mechanism(s) of anaphylactoid reactions to muscle relaxant drugs. Ann Fr Anesth Reanim 1985; 4: 139-45.
27. Baldo BA, Fisher MM. Anaphylaxis to muscle relaxant drugs: cross-reactivity and molecular basis of binding of IgE antibodies detected by radioimmunoassay. Mol Immunol 1983; 20: 1393-400.
28. Fisher MM, Munro I. Life-threatening anaphylactoid reactions to muscle relaxants. Anesth Analg 1983; 62: 559-64.
29. Fisher MM. Cisatracurium and atracurium as antigens. Anaesth Intensive Care 1999; 27: 369-70.
30. Hepner DL, Castells MC. Anaphylaxis during the perioperative period. Anesth Analg 2003; 97: 1381-95.
31. Anne S, Reisman RE. Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy. Ann Allergy Asthma Immunol 1995; 74: 167-70.
32. Fisher MM, Harle DG, Baldo BA. Anaphylactoid reactions to narcotic analgesics. Clin Rev Allergy 1991; 9: 309-18.
33. Laxenaire MC, Mertes PM, Groupe d'Etudes des Reactions Anaphylactoides Peranesthesiques. Anaphylaxis during anaesthesia: results of a two-year survey in France. Br J Anaesth 2001; 87: 549-58.
34. Hepner DL, Castells MC. Latex allergy: an update. Anesth Analg 2003; 96: 1219-29.
35. Fisher MM, Bowey CJ. Alleged allergy to local anaesthetics. Anaesth Intensive Care 1997; 25: 611-4.
36. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977; 1: 466-9.
37. Soreide E, Buxrud T, Harboe S. Severe anaphylactic reactions outside hospital: etiology, symptoms and treatment. Acta Anaesthesiol Scand 1988; 32: 339-42.
38. Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000; 30: 1144-50.
39. Simons FE, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol 2001; 108: 871-3.
40. Zaloga GP, DeLacey W, Holmboe E, Chernow B. Glucagon reversal of hypotension in a case of anaphylactoid shock. Ann Intern Med 1986; 105: 65-6.
41. Kill C, Wranze E, Wulf H. Successful treatment of severe anaphylactic shock with vasopressin: two case reports. Int Arch Allergy Immunol 2004; 134: 260-1.
42. Schwartz JC, Morisset S, Rouleau A, et al. Therapeutic implications of constitutive activity of receptors: the example of the histamine H3 receptor. J Neural Transm Suppl 2003; 20: 1-16.
43. Payne V, Kam PC. Mast cell tryptase: a review of its physiology and clinical significance. Anaesthesia 2004; 59: 695-703.
44. Fisher MM, Baldo BA. Mast cell tryptase in anaesthetic anaphylactoid reactions. Br J Anaesth 1998; 80: 26-9.
45. Fisher MM, Baldo BA. The diagnosis of fatal anaphylactic reactions during anaesthesia: employment of immunoassays for mast cell tryptase and drug-reactive IgE antibodies. Anaesth Intensive Care 1993; 21: 353-7.
46. Fisher MM, Bowey CJ. Intradermal compared with prick testing in the diagnosis of anaesthetic allergy. Br J Anaesth 1997; 79: 59-63.
47. Leynadier F, Sansarricq M, Didier JM, Dry J. Prick tests in the diagnosis of anaphylaxis to general anaesthetics. Br J Anaesth 1987; 59: 683-9.
48. Fisher MM. Intradermal testing in the diagnosis of acute anaphylaxis during anaesthesia: results of five years experience. Anaesth Intensive Care 1979; 7: 58-61.
49. Berg CM, Heier T, Wilhelmsen V, Florvaag E. Rocuronium and cisatracurium-positive skin tests in nonallergic volunteers: determination of drug concentration thresholds using a dilution titration technique. Acta Anaesthesiol Scand 2003; 47: 576-82.
50. Levy JH. Anaphylactic reactions to neuromuscular blocking drugs: are we making the correct diagnosis? Anesth Analg 2004; 98: 881-2.
51. Dhonneur G, Combes X, Chassard D, Merle JC. Skin sensitivity to rocuronium and vecuronium: a randomized controlled prick-testing study in healthy volunteers. Anesth Analg 2000; 98: 986-9.
52. Thomas H, Eledjam JJ, Macheboeuf M, et al. Rapid preoperative immunotherapy in a patient allergic to muscle relaxants. Eur J Anaesth 1988; 5: 385-9.
53. Fisher MM, Baldo BA. Immunoassays in the diagnosis of anaphylaxis to neuromuscular blocking drugs: the value of morphine for the detection of IgE antibodies in allergic subjects. Anaesth Intensive Care 2000; 28: 167-70.